Cultural Adaptation, Validity, and Reliability of the Turkish Version of The PASTUL Questionnaire
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Questionnaire study.
- Who it may be relevant to
- Registry conditions: Systemic Sclerosis (SSc), Systemic Sclerosis (Scleroderma), Scleroderma (Limited and Diffuse), Patient Perspective. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Cultural Adaptation, Validity, and Reliability of the Turkish Version of the Patient Assessment of Skin Thickness in the Upper Limb - PASTUL Questionnaire
Overview
The Patient Self-Assessment of Skin Thickness in Upper Limb (PASTUL) questionnaire was developed to enable patients to assess skin thickness in systemic sclerosis (SSc) physically and has been validated for reliability and validity, as it correlates with the modified Rodnan Skin Score (mRSS), which rheumatologists assess. Thus, it has been demonstrated to be an applicable and easy approach for assessing skin thickness in SSc patients through patient-reported measurements. This study aimed to develop a Turkish version of the PASTUL questionnaire and to provide for its use in the Turkish population.
Interventions
- Other Questionnaire study
Questionnaire application
Primary outcome measures
- Patient Self-Assessment of Skin Thickness in Upper Limb (PASTUL) Questionnaire [Time frame: Two weeks]
Secondary outcome measures (7)
- Scleroderma Health Assessment Questionnaire (SHAQ) [Time frame: Two weeks]
- Cognitive Exercise Therapy Approach-Biopsychosocial Questionnaire (BETY-BQ) [Time frame: Two weeks]
- Short Form-36 (SF-36) [Time frame: Two weeks]
- Modified Rodnan skin score (MRSS) [Time frame: Two weeks]
- Modified Hand Mobility in Scleroderma Test (mHAMIS) [Time frame: Two weeks]
- Scleroderma Skin Patient-Reported Outcomes (SSPRO) Questionnaire [Time frame: Two weeks]
- Cochin Hand Function Scale [Time frame: Two weeks]
Eligibility criteria
Inclusion criteria
- Individuals diagnosed with scleroderma,
- Individuals aged 18 years and older
Exclusion criteria
- Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
- Individuals who are unwilling to participate
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Turkey (Türkiye) · 1 center
- Hacettepe University — Çankaya
Identifiers
NCT: NCT07182968 · SBA 24/531